Success Metrics

Active Trials
3(60%)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(5)

Detailed Status

Recruiting3
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting360%
enrolling_by_invitation120%
not_yet_recruiting120%

Recent Activity

3 active trials
Showing 5 of 5
recruiting

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

NCT06252493
enrolling_by_invitation

PET/MRI for Evaluation of Endometriosis

NCT06377553
not_yet_recruiting

PET/MRI of Primary Sclerosing Cholangitis

NCT06252610
recruiting

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

NCT06265272
recruitingnot_applicable

Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression

NCT05808153

Clinical Trials (5)

Showing 5 of 5 trials
NCT06252493

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

Recruiting
NCT06377553

PET/MRI for Evaluation of Endometriosis

Enrolling By Invitation
NCT06252610

PET/MRI of Primary Sclerosing Cholangitis

Not Yet Recruiting
NCT06265272

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Recruiting
NCT05808153Not Applicable

Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression

Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5